PorterLamb
03-28

$Zai Lab Ltd(ZLAB)$ The beauty of investing in innovative pharmaceuticals lies in the rewards of patience and conviction. In just one year, Zai Lab's stock has tripled despite experiencing multiple major pullbacks, each offering new opportunities.

Now, with the NMPA officially accepting the BLA application for its breakthrough drug, Tisotumab Vedotin, This is not only an important milestone for the company, but also the highlight moment I have been looking forward to for a long time.

Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment